Literature DB >> 7069838

Computerized tomography: how accurate for abdominal staging of testis tumors?

J P Richie, M B Garnick, H Finberg.   

Abstract

To assess the ability of computerized tomography to predict correctly the presence of retroperitoneal lymphadenopathy, a prospective study was performed on 30 patients with all stages of testis tumor. All patients underwent a computerized tomography scan within 1 week before retroperitoneal lymphadenectomy and the results then were correlated with gross and histologic findings. The computerized tomography scan suggested retroperitoneal lymphadenopathy in 14 patients, in 1 of whom no retroperitoneal lymphadenopathy was found at exploration (false positive, 7 per cent). The sensitivity (computerized tomography negative divided by true positive) was 90 per cent, for an over-all accuracy of 73 per cent. Most importantly, however, 7 of the 16 computerized tomography scans (44 per cent) interpreted as normal proved to be false negative. Of these 7 scans 5 were in patients with tumors classified as stage B2 or greater. We conclude that the computerized tomography scan, when positive, is highly likely to detect metastatic nodal involvement. However, the false negative rate, even in patients with tumor-filled lymph nodes 2 to 3 cm. in diameter, limits the reliability of a negative computerized tomography scan to exclude metastases. Technological improvements are needed to refine the technique and, thus, to reduce the false negative rate.

Entities:  

Mesh:

Year:  1982        PMID: 7069838     DOI: 10.1016/s0022-5347(17)54013-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors.

Authors:  Samdeep K Mouli; Lee C Zhao; Reed A Omary; C Shad Thaxton
Journal:  Nat Rev Urol       Date:  2010-01-19       Impact factor: 14.432

Review 2.  Radiologic imaging modalities, including magnetic resonance, for evaluating lymph nodes.

Authors:  G C Dooms; H Hricak
Journal:  West J Med       Date:  1986-01

3.  Staging testicular tumours: the role of CT scanning.

Authors:  J E Husband; D P Grimer
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

4.  Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience.

Authors:  Shaheen R Alanee; Brett S Carver; Darren R Feldman; Robert J Motzer; George J Bosl; Joel Sheinfeld
Journal:  Urology       Date:  2016-05-25       Impact factor: 2.649

5.  Imaging of testicular germ cell tumours.

Authors:  P U Dalal; S A Sohaib; R Huddart
Journal:  Cancer Imaging       Date:  2006-09-07       Impact factor: 3.909

6.  Rapid progression of a germ cell tumor encasing the inferior vena cava and aorta following a radical orchiectomy.

Authors:  Hekmat Hakiman; Vitaly Margulis; Payal Kapur; Sergio Huerta
Journal:  Rare Tumors       Date:  2013-06-07

7.  Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse.

Authors:  N J van As; D C Gilbert; J Money-Kyrle; D Bloomfield; S Beesley; D P Dearnaley; A Horwich; R A Huddart
Journal:  Br J Cancer       Date:  2008-06-17       Impact factor: 7.640

Review 8.  Lymph node imaging in testicular cancer.

Authors:  Graham R Hale; Seth Teplitsky; Hong Truong; Samuel A Gold; Jonathan B Bloom; Piyush K Agarwal
Journal:  Transl Androl Urol       Date:  2018-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.